Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by The Bioverge Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bioverge Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Speeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies

50:20
 
Share
 

Manage episode 374315463 series 2874357
Content provided by The Bioverge Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bioverge Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
David Li, Co-Founder and CEO of Meliora Therapeutics, sits down with Neil to discuss why the mechanism of action for cancer therapies in development is poorly understood, how this leads to a high and costly clinical failure rate, and how Meliora's platform technology uncovers the true mechanism of action of a drug and it enables it to identify promising drug scaffolds to accelerate the development process.
  continue reading

43 episodes

Artwork
iconShare
 
Manage episode 374315463 series 2874357
Content provided by The Bioverge Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Bioverge Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
David Li, Co-Founder and CEO of Meliora Therapeutics, sits down with Neil to discuss why the mechanism of action for cancer therapies in development is poorly understood, how this leads to a high and costly clinical failure rate, and how Meliora's platform technology uncovers the true mechanism of action of a drug and it enables it to identify promising drug scaffolds to accelerate the development process.
  continue reading

43 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play